5 completed, 1 not yet recruiting. 2 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 3 | 1 | Not yet recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Vaccination Adverse Event: new trials by email Literature Review of Vaccination Adverse Event trials Research Report on Vaccination Adverse Event
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Interchangeability Hep-B Vaccine Administered at Birth Dose In-house Hepatitis B Vaccine, Registered Hepatitis B Vaccine - Vaccination Adverse Event, Immunogenicity, Vaccine | Phase 3 | Not yet recruiting | PT Bio Farma | 270 | 2026-10-01 | 2026-10-02 |
| A Post-marketing Safety Study of Inactivated, Split-virion Influenza Vaccine in Subjects Aged 3 Years and Older Influenza, Vaccination Adverse Event | Completed | Centers for Disease Control and Prevention, China | 166240 | 2014-01-01 | 2014-05-08 | |
| A Post-marketing Safety Study of Beijing Tiantan Biological's Influenza Virus Vaccine in Elderly Influenza, Vaccination Adverse Event | Completed | Centers for Disease Control and Prevention, China | 536812 | 2013-06-01 | 2013-07-24 | |
| The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use Zagreb2-1-1, Essen - Rabies Vaccine Allergy, Vaccination Adverse Event | Phase 4 | Completed | Beijing Center for Disease Control and Prevention | 10500 | 2012-07-01 | 2016-01-20 |
| PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae PCV7 (Pneumococcal 7-Valent Conjugate Vaccine), Hib Vaccine - Streptococcal Pneumonia, Nasopharyngeal Diseases | Not applicable | Completed | Centers for Disease Control and Prevention, China | 3281 | 2012-06-01 | 2016-05-20 |
| A Study to Assess the Acceptability and Usability of a New Device for Intradermal Vaccination Intradermal injection in the forearm (0,1cc NaCl 0,9%), Intradermal injection in the upper arm (0,1cc NaCl 0,9%), Intramuscular injection in the upper arm (0,5cc NaCl 0,9%) - Pain, Vaccination Adverse Event | Not applicable | Completed | Pierre Van Damme | 102 | 2012-04-01 | 2016-03-17 |
Influenza, Human (2) · Hepatitis B (1) · Nasopharyngeal Diseases (1) · Pain (1) · Pneumonia (1)
Infections (4) · Respiratory Tract Diseases (3) · Respiratory Tract Infections (3) · Virus Diseases (3) · Orthomyxoviridae Infections (2) · RNA Virus Infections (2) · Blood-Borne Infections (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Digestive System Diseases (1) · Hepadnaviridae Infections (1) · Hepatitis (1) · Hepatitis, Viral, Human (1) · Liver Diseases (1) · Lung Diseases (1)
Heptavalent Pneumococcal Conjugate Vaccine (1) · HibTITER protein, Haemophilus influenzae (1) · Injections, Intradermal (1) · Injections, Intramuscular (1) · Pneumococcal Vaccines (1)
Centers for Disease Control and Prevention, China (3) · Beijing Center for Disease Control and Prevention (1) · PT Bio Farma (1) · Pierre Van Damme (1)
China (2) · Belgium (1)
Jiang Wu, Master (2) · Nianmin Shi (1) · Pierre Van Damme, Prof. (1) · Rodman Tarigan Girsang, MD (1) · Wu Jiang, Bachelor (1)